导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 24.63% | 156/4773 |
| 近一周 | -2.62% | 2703/5462 |
| 近一月 | -10.41% | 5063/5421 |
| 近一季 | -14.33% | 4143/5209 |
| 近半年 | 19.80% | 165/4920 |
| 近一年 | 29.73% | 194/4366 |
| 近两年 | 183.29% | 96/2954 |
| 近三年 | 123.26% | 55/2253 |
| 成立以来 | 79.77% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.34% 4105/4961 |
108.37% 55/5312 |
- - |
- - |
| 2025 | 41.00% 750/4813 |
0.58% 1812/3635 |
-0.34% 2898/4076 |
53.81% 237/4524 |
-8.54% 3933/4813 |
| 2024 | 31.27% 99/3463 |
-9.50% 2285/2808 |
0.53% 585/3014 |
18.77% 938/3129 |
21.48% 30/3463 |
| 2023 | -6.48% 845/2656 |
14.56% 236/2280 |
-8.33% 1985/2385 |
-9.88% 1906/2515 |
-1.19% 298/2655 |
| 2022 | -38.74% 1764/2207 |
-21.95% 1671/1919 |
0.84% 1522/2016 |
-21.68% 1910/2113 |
-0.63% 1631/2208 |
| 2021 | 33.61% 51/1822 |
-8.47% 1087/1255 |
41.54% 16/1330 |
-3.18% 618/1466 |
6.52% 212/1822 |
| 2020 | - - |
- - |
30.42% 54/1067 |
-3.18% 1088/1164 |
7.00% 733/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 华夏国证半导体芯片ETF VS. 长安沪深300非周期A(740101) |